This archive report was first published on 8 June 2020.
On June 8, 2020, Genghis Capital, a prominent investment bank in Kenya, announced a strategic partnership with EGM Securities, an online non-dealing forex broker, to expand its services to a broader range of alternative asset classes.
The partnership grants Genghis Capital access to a diverse array of assets, including online currencies, commodities, global indices, precious metals, and oil, as well as high-demand stocks.
With this partnership, Genghis Capital's clients can now trade tech stocks such as Zoom, global banking stocks, pharmaceuticals, and biotech companies like Moderna and Gilead Sciences, which are working towards a coronavirus vaccine.
Partnership Details ¶
Mr. Samwel Kiraka, CEO of EGM Securities, stated that his firm is part of a global group of companies with access to teams of specialists who can efficiently develop effective solutions for banks and brokerage houses.
EGM Securities is a subsidiary of the Equiti Group, a global company with subsidiaries across the world, including Equiti Capital, which is regulated by the Financial Conduct Authority (FCA) in the UK.
Mr. Kiraka expressed EGM Securities' ambition to become the premier provider of multi-asset products in Kenya, East Africa, and the rest of Africa, citing the partnership with Genghis Capital as a key step towards achieving this goal.
Benefits for Clients ¶
According to Kenneth Minjire, Head of Securities for Genghis Capital, the partnership with EGM Securities will enable clients to trade for themselves in the global space and diversify their investments across various asset classes.
Mr. Kiraka emphasized that the partnership is a natural fit, given EGM Securities' regulation by the Capital Markets Authority of Kenya and Genghis Capital's sophisticated clients willing to explore new asset classes for attractive returns.
